Fertility Testing Devices Market Size, Share & Trends Analysis Report By Product (Ovulation Prediction Kits, Fertility Monitors), By Application (Female, Male), By End-use (Home Care Settings, Hospitals, Fertility Clinics), By Region, And Segment Forecast
Description
Fertility Testing Devices Market Summary
The global fertility testing devices market size was estimated at USD 2.47 billion in 2024 and is expected to reach USD 4.71 billion by 2033, growing at a CAGR of 7.50% from 2025 to 2033. Rising awareness about fertility health, delayed parenthood and lifestyle changes, technological advancements in home testing devices, and preference for at-home and non-invasive testing are some of the factors driving industry growth.
Furthermore, the growth of IVF and other ART procedures encourages pre-conception monitoring using fertility devices, thereby escalating market growth. Many women are choosing to start families later due to career priorities, higher education, and personal goals. Delaying parenthood can affect fertility, leading to increased interest in monitoring reproductive health.
The table shows a clear shift toward older maternal ages, with the proportion of first births among women aged 30-34 and 35+ steadily increasing from 2016 to 2023, highlighting delayed parenthood and supporting the growing demand for fertility testing devices.
In addition to delayed parenthood, lifestyle factors significantly impact reproductive health for both men and women. High stress levels, irregular sleep patterns, poor dietary habits, limited physical activity, and smoking reduce fertility in men and women. Smoking in men has been linked to reduced sperm count, motility, and overall semen quality, while in women, it affects ovarian reserve and conception rates. For instance, as per the Global Action to End Smoking, in 2022, approximately 253.0 million individuals (200.2 million males and 53.5 million females) aged 15 and above were users of tobacco products in India. These lifestyle challenges have led many individuals to actively monitor their reproductive health through home-based and non-invasive fertility testing devices.
Furthermore, the increasing prevalence of infertility worldwide has boosted demand for fertility testing devices for both men and women. A WHO report published in 2023 states that about 17.5% of adults, roughly 1 in 6 people globally, face infertility, emphasizing the critical need for improved access to affordable, high-quality care for those affected. Contributing factors include hormonal imbalances, reproductive conditions like polycystic ovary syndrome (PCOS) in women, and decreasing sperm quality in men.
Global Fertility Testing Devices Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global fertility testing devices market report based on product, application, end-use, and region:
The global fertility testing devices market size was estimated at USD 2.47 billion in 2024 and is expected to reach USD 4.71 billion by 2033, growing at a CAGR of 7.50% from 2025 to 2033. Rising awareness about fertility health, delayed parenthood and lifestyle changes, technological advancements in home testing devices, and preference for at-home and non-invasive testing are some of the factors driving industry growth.
Furthermore, the growth of IVF and other ART procedures encourages pre-conception monitoring using fertility devices, thereby escalating market growth. Many women are choosing to start families later due to career priorities, higher education, and personal goals. Delaying parenthood can affect fertility, leading to increased interest in monitoring reproductive health.
The table shows a clear shift toward older maternal ages, with the proportion of first births among women aged 30-34 and 35+ steadily increasing from 2016 to 2023, highlighting delayed parenthood and supporting the growing demand for fertility testing devices.
In addition to delayed parenthood, lifestyle factors significantly impact reproductive health for both men and women. High stress levels, irregular sleep patterns, poor dietary habits, limited physical activity, and smoking reduce fertility in men and women. Smoking in men has been linked to reduced sperm count, motility, and overall semen quality, while in women, it affects ovarian reserve and conception rates. For instance, as per the Global Action to End Smoking, in 2022, approximately 253.0 million individuals (200.2 million males and 53.5 million females) aged 15 and above were users of tobacco products in India. These lifestyle challenges have led many individuals to actively monitor their reproductive health through home-based and non-invasive fertility testing devices.
Furthermore, the increasing prevalence of infertility worldwide has boosted demand for fertility testing devices for both men and women. A WHO report published in 2023 states that about 17.5% of adults, roughly 1 in 6 people globally, face infertility, emphasizing the critical need for improved access to affordable, high-quality care for those affected. Contributing factors include hormonal imbalances, reproductive conditions like polycystic ovary syndrome (PCOS) in women, and decreasing sperm quality in men.
Global Fertility Testing Devices Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global fertility testing devices market report based on product, application, end-use, and region:
- Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Ovulation Prediction Kits
- Fertility Monitors:
- Male Fertility Testing Devices
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Female Fertility Testing
- Male Fertility Testing
- End-use Outlook (Revenue, USD Billion, 2021 - 2033)
- Home Care Settings
- Hospitals
- Fertility Clinics
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Fertility Testing Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Delayed parenthood and changing family planning trends
- 3.2.1.2. Increased prevalence of lifestyle-related fertility issues
- 3.2.1.3. Growing adoption of at-home fertility testing
- 3.2.2. Market restraint analysis
- 3.2.2.1. Social Stigma Associated with Fertility Testing
- 3.2.2.2. Accuracy and Reliability Concerns
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter’s Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- Chapter 4. Fertility Testing Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)
- 4.1. Fertility Testing Devices Market: Product Movement Analysis and Market Share
- 4.2. Fertility Testing Devices Market: Product Segment Dashboard
- 4.3. Ovulation prediction kits
- 4.3.1. Ovulation prediction kits market, 2021 - 2033 (USD Million)
- 4.4. Fertility monitors
- 4.4.1. Fertility monitors market, 2021 - 2033 (USD Million)
- 4.5. Male fertility testing devices
- 4.5.1. Male fertility testing devices market, 2021 - 2033 (USD Million)
- Chapter 5. Fertility Testing Devices Market Segment Analysis, By Application, 2021 - 2033 (USD Million)
- 5.1. Fertility Testing Devices Market: Application Movement Analysis and Market Share
- 5.2. Fertility Testing Devices Market: Application Segment Dashboard
- 5.3. Female fertility testing
- 5.3.1. Female fertility testing market, 2021 - 2033 (USD Million)
- 5.4. Male fertility testing
- 5.4.1. Male fertility testing market, 2021 - 2033 (USD Million)
- Chapter 6. Fertility Testing Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
- 6.1. Fertility Testing Devices Market: End Use Movement Analysis and Market Share
- 6.2. Fertility Testing Devices Market: End Use Segment Dashboard
- 6.3. Home care settings
- 6.3.1. Home care settings market, 2021 - 2033 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market, 2021 - 2033 (USD Million)
- 6.5. Fertility clinics
- 6.5.1. Fertility clinics market, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Others market, 2021 - 2033 (USD Million)
- Chapter 7. Fertility Testing Devices Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Dashboard
- 7.2. Regional marketplace: Key takeaways
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7. Middle East & Africa
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive scenario
- 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market position analysis, 2024
- 8.4. Company Profiles
- 8.4.1. viO HealthTech Inc
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Accuquik
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. SPD Swiss Precision Diagnostics GmbH
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Tempdrop
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Inito Health Tech Private Limited
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Mira
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. YO Home Sperm Test
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Geratherm Medical AG
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. bioZhena Corporation
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Eli Health
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
